FDA and other regulatory bodies have been working to develop a regulatory framework for NGS applications in various fields based on validated analytical standards that would ensure that NGS tests produce accurate and reliable results.
Additionally, growing challenges in data storage, management, processing, integration and validation for quality has opened new doors to fasten the turnaround time in data analysis. This conference will focus on Omics and NGS with upcoming advancements and technologies like single cell sequencing, artificial intelligence, which will give a platform to combine unique perspectives from a variety of researchers, engineers, biostatisticians and software developers from pharma and research community involved in data analysis.
This conference is co-located with our 3rd Annual Biomarker Conference and 3rd Annual Genome Editing and Engineering Conference
0 DAY EVENT
0 Hours of Networking